

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.55528849 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.55528849 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.32868813 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.32868813 |
| 5 | negative regulation of fibrinolysis (GO:0051918) | 5.76083778 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.74509206 |
| 7 | sulfur amino acid catabolic process (GO:0000098) | 5.50834801 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.50374665 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 5.46856004 |
| 10 | regulation of fibrinolysis (GO:0051917) | 5.36000427 |
| 11 | cysteine metabolic process (GO:0006534) | 5.34984168 |
| 12 | type B pancreatic cell proliferation (GO:0044342) | 5.29958863 |
| 13 | protein carboxylation (GO:0018214) | 5.15728722 |
| 14 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.15728722 |
| 15 | complement activation, alternative pathway (GO:0006957) | 5.15437933 |
| 16 | tryptophan catabolic process (GO:0006569) | 5.12754640 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 5.12754640 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 5.12754640 |
| 19 | regulation of protein activation cascade (GO:2000257) | 5.10581996 |
| 20 | bile acid biosynthetic process (GO:0006699) | 5.09442794 |
| 21 | kynurenine metabolic process (GO:0070189) | 5.09167040 |
| 22 | urea metabolic process (GO:0019627) | 5.05450876 |
| 23 | urea cycle (GO:0000050) | 5.05450876 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 4.99729668 |
| 25 | skin morphogenesis (GO:0043589) | 4.98338717 |
| 26 | glyoxylate metabolic process (GO:0046487) | 4.88214767 |
| 27 | tryptophan metabolic process (GO:0006568) | 4.85551544 |
| 28 | regulation of complement activation (GO:0030449) | 4.79876909 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.65376395 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.63020546 |
| 31 | reverse cholesterol transport (GO:0043691) | 4.52606295 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.51344326 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.48408981 |
| 34 | protein heterotrimerization (GO:0070208) | 4.42465887 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.39669202 |
| 36 | endodermal cell differentiation (GO:0035987) | 4.37702288 |
| 37 | bile acid metabolic process (GO:0008206) | 4.32342737 |
| 38 | adhesion of symbiont to host cell (GO:0044650) | 4.28985792 |
| 39 | virion attachment to host cell (GO:0019062) | 4.28985792 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.25529859 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.25529859 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.25529859 |
| 43 | triglyceride homeostasis (GO:0070328) | 4.18793299 |
| 44 | acylglycerol homeostasis (GO:0055090) | 4.18793299 |
| 45 | phospholipid efflux (GO:0033700) | 4.18755961 |
| 46 | extracellular matrix assembly (GO:0085029) | 4.16600376 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 4.16504072 |
| 48 | aromatic amino acid family metabolic process (GO:0009072) | 4.15173534 |
| 49 | bone trabecula formation (GO:0060346) | 4.11425053 |
| 50 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.11209510 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 4.07346403 |
| 52 | plasma lipoprotein particle clearance (GO:0034381) | 4.06952919 |
| 53 | lysine metabolic process (GO:0006553) | 4.06779310 |
| 54 | lysine catabolic process (GO:0006554) | 4.06779310 |
| 55 | tyrosine metabolic process (GO:0006570) | 4.05685729 |
| 56 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.05433698 |
| 57 | fibrinolysis (GO:0042730) | 4.01176063 |
| 58 | alpha-amino acid catabolic process (GO:1901606) | 4.00833563 |
| 59 | cellular modified amino acid catabolic process (GO:0042219) | 3.98382880 |
| 60 | ethanol oxidation (GO:0006069) | 3.95232467 |
| 61 | Golgi transport vesicle coating (GO:0048200) | 3.94327823 |
| 62 | COPI coating of Golgi vesicle (GO:0048205) | 3.94327823 |
| 63 | coenzyme catabolic process (GO:0009109) | 3.88798146 |
| 64 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.86791250 |
| 65 | adhesion of symbiont to host (GO:0044406) | 3.85244678 |
| 66 | cell adhesion mediated by integrin (GO:0033627) | 3.84489150 |
| 67 | regulation of plasminogen activation (GO:0010755) | 3.83919871 |
| 68 | protein localization to endosome (GO:0036010) | 3.83560467 |
| 69 | barbed-end actin filament capping (GO:0051016) | 3.83150970 |
| 70 | negative regulation of sterol transport (GO:0032372) | 3.82333934 |
| 71 | negative regulation of cholesterol transport (GO:0032375) | 3.82333934 |
| 72 | bile acid and bile salt transport (GO:0015721) | 3.81637273 |
| 73 | glycine metabolic process (GO:0006544) | 3.81582479 |
| 74 | cellular amino acid catabolic process (GO:0009063) | 3.78560748 |
| 75 | negative regulation of lipase activity (GO:0060192) | 3.77196401 |
| 76 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.76464312 |
| 77 | intestinal cholesterol absorption (GO:0030299) | 3.76414861 |
| 78 | kidney mesenchyme development (GO:0072074) | 3.75703183 |
| 79 | cholesterol efflux (GO:0033344) | 3.75612696 |
| 80 | protein retention in ER lumen (GO:0006621) | 3.75559966 |
| 81 | extracellular fibril organization (GO:0043206) | 3.75068442 |
| 82 | blood vessel maturation (GO:0001955) | 3.73763503 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 3.72991679 |
| 84 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.72539057 |
| 85 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.72539057 |
| 86 | collagen fibril organization (GO:0030199) | 3.70070646 |
| 87 | glutamate metabolic process (GO:0006536) | 3.66452803 |
| 88 | acute-phase response (GO:0006953) | 3.63834817 |
| 89 | epoxygenase P450 pathway (GO:0019373) | 3.63160615 |
| 90 | hemidesmosome assembly (GO:0031581) | 3.61531988 |
| 91 | cell migration involved in heart development (GO:0060973) | 3.61417612 |
| 92 | indolalkylamine metabolic process (GO:0006586) | 3.60206518 |
| 93 | apoptotic cell clearance (GO:0043277) | 3.58360629 |
| 94 | lung vasculature development (GO:0060426) | 3.57371398 |
| 95 | regulation of cholesterol homeostasis (GO:2000188) | 3.56813043 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 3.56728814 |
| 97 | imidazole-containing compound metabolic process (GO:0052803) | 3.56004992 |
| 98 | cellular glucuronidation (GO:0052695) | 3.55993953 |
| 99 | cellular biogenic amine catabolic process (GO:0042402) | 3.53501995 |
| 100 | amine catabolic process (GO:0009310) | 3.53501995 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.53015657 |
| 102 | respiratory tube development (GO:0030323) | 3.52725141 |
| 103 | cellular ketone body metabolic process (GO:0046950) | 3.52693056 |
| 104 | arginine metabolic process (GO:0006525) | 3.52637926 |
| 105 | opsonization (GO:0008228) | 3.52197658 |
| 106 | benzene-containing compound metabolic process (GO:0042537) | 3.51951420 |
| 107 | positive regulation of lipid catabolic process (GO:0050996) | 3.51951083 |
| 108 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.50368860 |
| 109 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.50368860 |
| 110 | fibril organization (GO:0097435) | 3.49451373 |
| 111 | chondrocyte proliferation (GO:0035988) | 3.49434069 |
| 112 | serine family amino acid biosynthetic process (GO:0009070) | 3.48729553 |
| 113 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.48060983 |
| 114 | complement activation, classical pathway (GO:0006958) | 3.46271699 |
| 115 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.46267304 |
| 116 | cholesterol homeostasis (GO:0042632) | 3.45750030 |
| 117 | complement activation (GO:0006956) | 3.45514289 |
| 118 | basement membrane organization (GO:0071711) | 3.43833991 |
| 119 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.41982564 |
| 120 | protein activation cascade (GO:0072376) | 3.41817159 |
| 121 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.41730915 |
| 122 | sterol homeostasis (GO:0055092) | 3.40999751 |
| 123 | negative regulation of protein activation cascade (GO:2000258) | 3.39800002 |
| 124 | collagen metabolic process (GO:0032963) | 3.39253654 |
| 125 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.36443556 |
| 126 | linoleic acid metabolic process (GO:0043651) | 3.34974751 |
| 127 | cytolysis (GO:0019835) | 3.34211009 |
| 128 | lipoprotein metabolic process (GO:0042157) | 3.33499633 |
| 129 | acetyl-CoA metabolic process (GO:0006084) | 3.33206314 |
| 130 | organic acid catabolic process (GO:0016054) | 3.32972877 |
| 131 | carboxylic acid catabolic process (GO:0046395) | 3.32972877 |
| 132 | metanephric mesenchyme development (GO:0072075) | 3.31822815 |
| 133 | blood coagulation, intrinsic pathway (GO:0007597) | 3.31364554 |
| 134 | valine metabolic process (GO:0006573) | 3.31007134 |
| 135 | cell-substrate junction assembly (GO:0007044) | 3.30449325 |
| 136 | heme transport (GO:0015886) | 3.30348358 |
| 137 | plasma lipoprotein particle organization (GO:0071827) | 3.29843175 |
| 138 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.29697423 |
| 139 | aldehyde catabolic process (GO:0046185) | 3.28373486 |
| 140 | protein-lipid complex assembly (GO:0065005) | 3.27878716 |
| 141 | cofactor catabolic process (GO:0051187) | 3.27065256 |
| 142 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.27039807 |
| 143 | hypotonic response (GO:0006971) | 3.26362921 |
| 144 | collagen catabolic process (GO:0030574) | 3.24575058 |
| 145 | extracellular matrix disassembly (GO:0022617) | 3.21887980 |
| 146 | stress fiber assembly (GO:0043149) | 3.19661106 |
| 147 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.18115581 |
| 148 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.14666211 |
| 149 | pinocytosis (GO:0006907) | 3.13902657 |
| 150 | dermatan sulfate metabolic process (GO:0030205) | 3.13358026 |
| 151 | regulation of early endosome to late endosome transport (GO:2000641) | 3.12383071 |
| 152 | hyaluronan catabolic process (GO:0030214) | 3.11349649 |
| 153 | embryo implantation (GO:0007566) | 3.11137679 |
| 154 | keratan sulfate catabolic process (GO:0042340) | 3.09655717 |
| 155 | cellular response to vitamin (GO:0071295) | 3.07457171 |
| 156 | endocardial cushion development (GO:0003197) | 3.05875944 |
| 157 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.02797270 |
| 158 | regulation of extracellular matrix disassembly (GO:0010715) | 3.01886669 |
| 159 | regulation of response to osmotic stress (GO:0047484) | 3.01602216 |
| 160 | dermatan sulfate biosynthetic process (GO:0030208) | 3.00956192 |
| 161 | multicellular organismal catabolic process (GO:0044243) | 2.99417688 |
| 162 | substrate-dependent cell migration (GO:0006929) | 2.98132544 |
| 163 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.95371936 |
| 164 | multicellular organismal metabolic process (GO:0044236) | 2.94859070 |
| 165 | positive regulation of extracellular matrix organization (GO:1903055) | 2.93384003 |
| 166 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.92661999 |
| 167 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.92004823 |
| 168 | venous blood vessel morphogenesis (GO:0048845) | 2.90460598 |
| 169 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.89555451 |
| 170 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.89211361 |
| 171 | wound healing, spreading of epidermal cells (GO:0035313) | 2.88895756 |
| 172 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.84899499 |
| 173 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.80882580 |
| 174 | adherens junction assembly (GO:0034333) | 2.80126334 |
| 175 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.78929700 |
| 176 | positive regulation of receptor recycling (GO:0001921) | 2.77793228 |
| 177 | peptidyl-proline hydroxylation (GO:0019511) | 2.77250963 |
| 178 | mannose metabolic process (GO:0006013) | 2.77014586 |
| 179 | extracellular matrix organization (GO:0030198) | 2.75270474 |
| 180 | extracellular structure organization (GO:0043062) | 2.74175363 |
| 181 | tooth mineralization (GO:0034505) | 2.73198298 |
| 182 | negative regulation of osteoblast proliferation (GO:0033689) | 2.71230586 |
| 183 | chondroitin sulfate catabolic process (GO:0030207) | 2.71074751 |
| 184 | regulation of collagen metabolic process (GO:0010712) | 2.68930765 |
| 185 | mesodermal cell differentiation (GO:0048333) | 2.68887456 |
| 186 | UV protection (GO:0009650) | 2.68201778 |
| 187 | diaphragm development (GO:0060539) | 2.68199654 |
| 188 | cell-substrate adherens junction assembly (GO:0007045) | 2.68088468 |
| 189 | focal adhesion assembly (GO:0048041) | 2.68088468 |
| 190 | cortical actin cytoskeleton organization (GO:0030866) | 2.67956671 |
| 191 | extracellular regulation of signal transduction (GO:1900115) | 2.67396416 |
| 192 | extracellular negative regulation of signal transduction (GO:1900116) | 2.67396416 |
| 193 | glial cell migration (GO:0008347) | 2.65483097 |
| 194 | protein hydroxylation (GO:0018126) | 2.65447631 |
| 195 | epithelial cell-cell adhesion (GO:0090136) | 2.64364723 |
| 196 | desmosome organization (GO:0002934) | 2.61860823 |
| 197 | endocytic recycling (GO:0032456) | 2.61541897 |
| 198 | establishment of apical/basal cell polarity (GO:0035089) | 2.59540273 |
| 199 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.59059017 |
| 200 | surfactant homeostasis (GO:0043129) | 2.56607903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.20765716 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.26886235 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.72658852 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.57739258 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.14792753 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.53297624 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.23633637 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.66099225 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.15657544 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.58015644 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.55500622 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.45190033 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.35136212 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.01608948 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.2522384 |
| 16 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.99182809 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.97127450 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.92562252 |
| 19 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.92006137 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.90678968 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.84212368 |
| 22 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.83526333 |
| 23 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.79060964 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.77942440 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.76910122 |
| 26 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.74528296 |
| 27 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.68298794 |
| 28 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.65747036 |
| 29 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.60051524 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56104776 |
| 31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55116731 |
| 32 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.54880823 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53088559 |
| 34 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.52664741 |
| 35 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.48596928 |
| 36 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.46557544 |
| 37 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.46017890 |
| 38 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.43188113 |
| 39 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42255534 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39791036 |
| 41 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.39677179 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37495041 |
| 43 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.35427279 |
| 44 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.34482061 |
| 45 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.34410480 |
| 46 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32384745 |
| 47 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.32334210 |
| 48 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.30663477 |
| 49 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.30124546 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29770606 |
| 51 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.26914098 |
| 52 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.22537156 |
| 53 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.22183783 |
| 54 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.21284684 |
| 55 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19878384 |
| 56 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18454297 |
| 57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18423538 |
| 58 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.17356927 |
| 59 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17349316 |
| 60 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.16872663 |
| 61 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15005862 |
| 62 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.13706867 |
| 63 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12684299 |
| 64 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12671850 |
| 65 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12097335 |
| 66 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.09712277 |
| 67 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09149076 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08730493 |
| 69 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08540743 |
| 70 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08082306 |
| 71 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.08066141 |
| 72 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.07748619 |
| 73 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06974362 |
| 74 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06384198 |
| 75 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05239223 |
| 76 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.04040306 |
| 77 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.03628193 |
| 78 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.03349482 |
| 79 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.03306434 |
| 80 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.03210548 |
| 81 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01986391 |
| 82 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.00421693 |
| 83 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00075963 |
| 84 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.99599915 |
| 85 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99249080 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94020346 |
| 87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94020346 |
| 88 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93545701 |
| 89 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.93153503 |
| 90 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92244213 |
| 91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92171560 |
| 92 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.92032946 |
| 93 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91233496 |
| 94 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90621502 |
| 95 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.90302027 |
| 96 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.88474154 |
| 97 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88053252 |
| 98 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88002149 |
| 99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87282199 |
| 100 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86819556 |
| 101 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86057713 |
| 102 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.85943422 |
| 103 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81853440 |
| 104 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81218144 |
| 105 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.79161489 |
| 106 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78472638 |
| 107 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.76488999 |
| 108 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76036677 |
| 109 | ATF3_27146783_Chip-Seq_COLON_Human | 0.75839680 |
| 110 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.75373261 |
| 111 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.75006928 |
| 112 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.74927697 |
| 113 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.74615887 |
| 114 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.74337954 |
| 115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73611651 |
| 116 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72995851 |
| 117 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.72039373 |
| 118 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71357246 |
| 119 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69574656 |
| 120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.69150748 |
| 121 | CJUN_26792858_Chip-Seq_BT549_Human | 0.68194225 |
| 122 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.67123122 |
| 123 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.67123122 |
| 124 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66821090 |
| 125 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65946721 |
| 126 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.65021759 |
| 127 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.64446462 |
| 128 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.64356782 |
| 129 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.63719429 |
| 130 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.63194932 |
| 131 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.63081216 |
| 132 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.62112649 |
| 133 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.61762718 |
| 134 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.61762718 |
| 135 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.61655957 |
| 136 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60544314 |
| 137 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.59094263 |
| 138 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.58883537 |
| 139 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58800366 |
| 140 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58303015 |
| 141 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.57817571 |
| 142 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.56977396 |
| 143 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.56897317 |
| 144 | GATA2_19941826_ChIP-Seq_K562_Human | 0.56063840 |
| 145 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55884893 |
| 146 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.54677728 |
| 147 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.54401222 |
| 148 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.53632237 |
| 149 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.52671700 |
| 150 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.51922936 |
| 151 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.51867877 |
| 152 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.51807678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.13532427 |
| 2 | MP0005360_urolithiasis | 6.29064570 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.58377436 |
| 4 | MP0005365_abnormal_bile_salt | 5.49577900 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.12643499 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.51165551 |
| 7 | MP0003252_abnormal_bile_duct | 3.42690243 |
| 8 | MP0005083_abnormal_biliary_tract | 3.36830567 |
| 9 | MP0005257_abnormal_intraocular_pressure | 3.29098072 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.23302053 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.95651223 |
| 12 | MP0009840_abnormal_foam_cell | 2.81617726 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.43123541 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.38796183 |
| 15 | MP0003195_calcinosis | 2.36950396 |
| 16 | MP0005332_abnormal_amino_acid | 2.35664466 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 2.26621812 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.04801136 |
| 19 | MP0003091_abnormal_cell_migration | 2.00620068 |
| 20 | MP0000609_abnormal_liver_physiology | 1.97073157 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.96828849 |
| 22 | MP0002877_abnormal_melanocyte_morpholog | 1.96024211 |
| 23 | MP0005623_abnormal_meninges_morphology | 1.93252378 |
| 24 | MP0003868_abnormal_feces_composition | 1.82645811 |
| 25 | MP0005508_abnormal_skeleton_morphology | 1.81852466 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.80795770 |
| 27 | MP0001849_ear_inflammation | 1.75550887 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.66377126 |
| 29 | MP0000767_abnormal_smooth_muscle | 1.65827336 |
| 30 | MP0005275_abnormal_skin_tensile | 1.59333687 |
| 31 | MP0004858_abnormal_nervous_system | 1.57820093 |
| 32 | MP0000751_myopathy | 1.46944680 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 1.42597585 |
| 34 | MP0003011_delayed_dark_adaptation | 1.42149778 |
| 35 | MP0005220_abnormal_exocrine_pancreas | 1.34909372 |
| 36 | MP0005390_skeleton_phenotype | 1.34462642 |
| 37 | MP0002254_reproductive_system_inflammat | 1.32589902 |
| 38 | MP0001881_abnormal_mammary_gland | 1.32588294 |
| 39 | MP0003941_abnormal_skin_development | 1.30487704 |
| 40 | MP0001764_abnormal_homeostasis | 1.27381428 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.26695506 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.24201202 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.23806652 |
| 44 | MP0009384_cardiac_valve_regurgitation | 1.22572043 |
| 45 | MP0002060_abnormal_skin_morphology | 1.21681699 |
| 46 | MP0003950_abnormal_plasma_membrane | 1.20661772 |
| 47 | MP0010030_abnormal_orbit_morphology | 1.19349346 |
| 48 | MP0005451_abnormal_body_composition | 1.18861769 |
| 49 | MP0010368_abnormal_lymphatic_system | 1.17600781 |
| 50 | MP0000858_altered_metastatic_potential | 1.17506410 |
| 51 | MP0003186_abnormal_redox_activity | 1.17081502 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.15486247 |
| 53 | MP0005076_abnormal_cell_differentiation | 1.14063699 |
| 54 | MP0003448_altered_tumor_morphology | 1.12300268 |
| 55 | MP0000598_abnormal_liver_morphology | 1.09313072 |
| 56 | MP0005670_abnormal_white_adipose | 1.08899353 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.08718843 |
| 58 | MP0002796_impaired_skin_barrier | 1.08637690 |
| 59 | MP0005595_abnormal_vascular_smooth | 1.07060260 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.06588712 |
| 61 | MP0009764_decreased_sensitivity_to | 1.05911507 |
| 62 | MP0000534_abnormal_ureter_morphology | 1.05128425 |
| 63 | MP0002108_abnormal_muscle_morphology | 1.03067571 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.02196928 |
| 65 | MP0000428_abnormal_craniofacial_morphol | 1.01902871 |
| 66 | MP0001299_abnormal_eye_distance/ | 1.01071304 |
| 67 | MP0000343_altered_response_to | 1.00890150 |
| 68 | MP0002933_joint_inflammation | 0.99934193 |
| 69 | MP0000733_abnormal_muscle_development | 0.98672513 |
| 70 | MP0005647_abnormal_sex_gland | 0.96510735 |
| 71 | MP0003942_abnormal_urinary_system | 0.94528868 |
| 72 | MP0010234_abnormal_vibrissa_follicle | 0.94130859 |
| 73 | MP0001348_abnormal_lacrimal_gland | 0.92903957 |
| 74 | MP0003115_abnormal_respiratory_system | 0.92497578 |
| 75 | MP0009763_increased_sensitivity_to | 0.91322582 |
| 76 | MP0005023_abnormal_wound_healing | 0.90623208 |
| 77 | MP0008260_abnormal_autophagy | 0.90414968 |
| 78 | MP0005084_abnormal_gallbladder_morpholo | 0.89094950 |
| 79 | MP0005636_abnormal_mineral_homeostasis | 0.87243298 |
| 80 | MP0003795_abnormal_bone_structure | 0.86175354 |
| 81 | MP0003329_amyloid_beta_deposits | 0.85609120 |
| 82 | MP0004510_myositis | 0.84729759 |
| 83 | MP0005165_increased_susceptibility_to | 0.84708208 |
| 84 | MP0005408_hypopigmentation | 0.84297842 |
| 85 | MP0009053_abnormal_anal_canal | 0.83865652 |
| 86 | MP0005197_abnormal_uvea_morphology | 0.83781710 |
| 87 | MP0005409_darkened_coat_color | 0.82166747 |
| 88 | MP0004130_abnormal_muscle_cell | 0.81669019 |
| 89 | MP0000681_abnormal_thyroid_gland | 0.81527104 |
| 90 | MP0009780_abnormal_chondrocyte_physiolo | 0.81483472 |
| 91 | MP0009697_abnormal_copulation | 0.81025434 |
| 92 | MP0003300_gastrointestinal_ulcer | 0.80809469 |
| 93 | MP0003566_abnormal_cell_adhesion | 0.80170199 |
| 94 | MP0008469_abnormal_protein_level | 0.79513608 |
| 95 | MP0000163_abnormal_cartilage_morphology | 0.79337052 |
| 96 | MP0000762_abnormal_tongue_morphology | 0.78754262 |
| 97 | MP0001243_abnormal_dermal_layer | 0.78475496 |
| 98 | MP0001614_abnormal_blood_vessel | 0.77942781 |
| 99 | MP0009642_abnormal_blood_homeostasis | 0.76817316 |
| 100 | MP0002113_abnormal_skeleton_development | 0.76352788 |
| 101 | MP0005388_respiratory_system_phenotype | 0.75599355 |
| 102 | MP0002133_abnormal_respiratory_system | 0.75599355 |
| 103 | MP0001915_intracranial_hemorrhage | 0.75005567 |
| 104 | MP0006082_CNS_inflammation | 0.75005418 |
| 105 | MP0000003_abnormal_adipose_tissue | 0.74970010 |
| 106 | MP0001175_abnormal_lung_morphology | 0.74536157 |
| 107 | MP0000604_amyloidosis | 0.74285123 |
| 108 | MP0000613_abnormal_salivary_gland | 0.71795250 |
| 109 | MP0002089_abnormal_postnatal_growth/wei | 0.71523132 |
| 110 | MP0005334_abnormal_fat_pad | 0.71356347 |
| 111 | MP0002128_abnormal_blood_circulation | 0.71342613 |
| 112 | MP0002295_abnormal_pulmonary_circulatio | 0.70784722 |
| 113 | MP0005666_abnormal_adipose_tissue | 0.70488782 |
| 114 | MP0005503_abnormal_tendon_morphology | 0.70226010 |
| 115 | MP0002168_other_aberrant_phenotype | 0.69647070 |
| 116 | MP0003453_abnormal_keratinocyte_physiol | 0.69592728 |
| 117 | MP0001756_abnormal_urination | 0.69183884 |
| 118 | MP0005395_other_phenotype | 0.68882279 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.68858350 |
| 120 | MP0004272_abnormal_basement_membrane | 0.68417303 |
| 121 | MP0005376_homeostasis/metabolism_phenot | 0.68213976 |
| 122 | MP0000467_abnormal_esophagus_morphology | 0.68157044 |
| 123 | MP0002971_abnormal_brown_adipose | 0.68152051 |
| 124 | MP0001542_abnormal_bone_strength | 0.67153836 |
| 125 | MP0000579_abnormal_nail_morphology | 0.65572288 |
| 126 | MP0000462_abnormal_digestive_system | 0.65565618 |
| 127 | MP0003279_aneurysm | 0.65279951 |
| 128 | MP0003828_pulmonary_edema | 0.64857006 |
| 129 | MP0000750_abnormal_muscle_regeneration | 0.64249692 |
| 130 | MP0000759_abnormal_skeletal_muscle | 0.63359704 |
| 131 | MP0010386_abnormal_urinary_bladder | 0.62119112 |
| 132 | MP0000432_abnormal_head_morphology | 0.62063472 |
| 133 | MP0003385_abnormal_body_wall | 0.61622678 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.61611019 |
| 135 | MP0002115_abnormal_skeleton_extremities | 0.61550860 |
| 136 | MP0010771_integument_phenotype | 0.60840786 |
| 137 | MP0005164_abnormal_response_to | 0.60727676 |
| 138 | MP0002249_abnormal_larynx_morphology | 0.59879468 |
| 139 | MP0001661_extended_life_span | 0.58956045 |
| 140 | MP0004264_abnormal_extraembryonic_tissu | 0.58908524 |
| 141 | MP0002876_abnormal_thyroid_physiology | 0.58159806 |
| 142 | MP0006054_spinal_hemorrhage | 0.57154861 |
| 143 | MP0005464_abnormal_platelet_physiology | 0.54869703 |
| 144 | MP0005501_abnormal_skin_physiology | 0.54775002 |
| 145 | MP0005448_abnormal_energy_balance | 0.54520955 |
| 146 | MP0005248_abnormal_Harderian_gland | 0.54013771 |
| 147 | MP0005058_abnormal_lysosome_morphology | 0.51513726 |
| 148 | MP0004782_abnormal_surfactant_physiolog | 0.51256172 |
| 149 | MP0004185_abnormal_adipocyte_glucose | 0.50425733 |
| 150 | MP0004947_skin_inflammation | 0.49171122 |
| 151 | MP0002896_abnormal_bone_mineralization | 0.48955295 |
| 152 | MP0002136_abnormal_kidney_physiology | 0.48132789 |
| 153 | MP0002928_abnormal_bile_duct | 0.48116749 |
| 154 | MP0000639_abnormal_adrenal_gland | 0.47956863 |
| 155 | MP0000249_abnormal_blood_vessel | 0.47376724 |
| 156 | MP0001958_emphysema | 0.47082849 |
| 157 | MP0003436_decreased_susceptibility_to | 0.46184814 |
| 158 | MP0001216_abnormal_epidermal_layer | 0.45938898 |
| 159 | MP0004883_abnormal_blood_vessel | 0.45356349 |
| 160 | MP0003724_increased_susceptibility_to | 0.45183637 |
| 161 | MP0000627_abnormal_mammary_gland | 0.44855628 |
| 162 | MP0008004_abnormal_stomach_pH | 0.44174900 |
| 163 | MP0009115_abnormal_fat_cell | 0.43766082 |
| 164 | MP0003638_abnormal_response/metabolism_ | 0.43162266 |
| 165 | MP0002098_abnormal_vibrissa_morphology | 0.42282915 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.05034506 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.47458118 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.30760514 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.03406316 |
| 5 | Xanthomatosis (HP:0000991) | 5.72100409 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.70967495 |
| 7 | Complement deficiency (HP:0004431) | 5.29497027 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.28427031 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.90373098 |
| 10 | Vascular tortuosity (HP:0004948) | 4.83954580 |
| 11 | Aortic aneurysm (HP:0004942) | 4.59980492 |
| 12 | Ankle contracture (HP:0006466) | 4.59653799 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.54121468 |
| 14 | Cervical subluxation (HP:0003308) | 4.39553213 |
| 15 | Arterial tortuosity (HP:0005116) | 4.35052231 |
| 16 | Joint hemorrhage (HP:0005261) | 4.25626845 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.24492391 |
| 18 | Vertebral compression fractures (HP:0002953) | 4.19058109 |
| 19 | Abnormality of the intrinsic pathway (HP:0010989) | 4.08017109 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.00307081 |
| 21 | Epidermoid cyst (HP:0200040) | 3.97124478 |
| 22 | Bladder diverticulum (HP:0000015) | 3.95418992 |
| 23 | Fat malabsorption (HP:0002630) | 3.94600034 |
| 24 | Abnormality of complement system (HP:0005339) | 3.93633888 |
| 25 | Hyperammonemia (HP:0001987) | 3.91502577 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.88546656 |
| 27 | Hyperglycinemia (HP:0002154) | 3.87665751 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.85906077 |
| 29 | Broad metatarsal (HP:0001783) | 3.81434604 |
| 30 | Ketosis (HP:0001946) | 3.71858726 |
| 31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.70933498 |
| 32 | Follicular hyperkeratosis (HP:0007502) | 3.64488208 |
| 33 | Atrophic scars (HP:0001075) | 3.64369241 |
| 34 | Wormian bones (HP:0002645) | 3.49781660 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 3.47612842 |
| 36 | Spondylolisthesis (HP:0003302) | 3.46083171 |
| 37 | Hyperglycinuria (HP:0003108) | 3.43254358 |
| 38 | Hypoglycemic coma (HP:0001325) | 3.42639230 |
| 39 | Soft skin (HP:0000977) | 3.42127559 |
| 40 | Spinal rigidity (HP:0003306) | 3.41373793 |
| 41 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.35732020 |
| 42 | Abnormality of glycine metabolism (HP:0010895) | 3.33673843 |
| 43 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.33673843 |
| 44 | Myocardial infarction (HP:0001658) | 3.24796880 |
| 45 | Type 1 muscle fiber predominance (HP:0003803) | 3.24259696 |
| 46 | Fragile skin (HP:0001030) | 3.19210027 |
| 47 | Abnormality of dentin (HP:0010299) | 3.15550436 |
| 48 | Shallow orbits (HP:0000586) | 3.14621938 |
| 49 | Steatorrhea (HP:0002570) | 3.11740187 |
| 50 | Dilatation of the ascending aorta (HP:0005111) | 3.11071443 |
| 51 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.10294499 |
| 52 | Conjugated hyperbilirubinemia (HP:0002908) | 3.09427958 |
| 53 | Hypercholesterolemia (HP:0003124) | 3.09298691 |
| 54 | Blue sclerae (HP:0000592) | 3.03985624 |
| 55 | Spontaneous abortion (HP:0005268) | 3.02155830 |
| 56 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.98822629 |
| 57 | Slender build (HP:0001533) | 2.96810796 |
| 58 | Abnormality of nucleobase metabolism (HP:0010932) | 2.95907422 |
| 59 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.93214444 |
| 60 | Cerebral aneurysm (HP:0004944) | 2.91265656 |
| 61 | Vascular calcification (HP:0004934) | 2.89261545 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.88713884 |
| 63 | Cardiovascular calcification (HP:0011915) | 2.86921802 |
| 64 | Neonatal short-limb short stature (HP:0008921) | 2.85583135 |
| 65 | Osteolytic defects of the hand bones (HP:0009699) | 2.83963294 |
| 66 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.83963294 |
| 67 | Skin nodule (HP:0200036) | 2.73744621 |
| 68 | Genu recurvatum (HP:0002816) | 2.73038832 |
| 69 | Hyperbilirubinemia (HP:0002904) | 2.72199017 |
| 70 | Protrusio acetabuli (HP:0003179) | 2.70859429 |
| 71 | Hepatocellular carcinoma (HP:0001402) | 2.69024998 |
| 72 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.68834722 |
| 73 | Increased variability in muscle fiber diameter (HP:0003557) | 2.68570785 |
| 74 | Aneurysm (HP:0002617) | 2.64476886 |
| 75 | Ketoacidosis (HP:0001993) | 2.62048752 |
| 76 | Joint laxity (HP:0001388) | 2.61774693 |
| 77 | Peritonitis (HP:0002586) | 2.61574072 |
| 78 | Dysostosis multiplex (HP:0000943) | 2.60252524 |
| 79 | Increased connective tissue (HP:0009025) | 2.58075602 |
| 80 | Gout (HP:0001997) | 2.56445760 |
| 81 | Malnutrition (HP:0004395) | 2.56033591 |
| 82 | Short nail (HP:0001799) | 2.54658734 |
| 83 | Systemic lupus erythematosus (HP:0002725) | 2.53893340 |
| 84 | Long toe (HP:0010511) | 2.51404654 |
| 85 | Mitral regurgitation (HP:0001653) | 2.49501698 |
| 86 | Aortic regurgitation (HP:0001659) | 2.49414828 |
| 87 | Distal upper limb amyotrophy (HP:0007149) | 2.48657368 |
| 88 | Upper limb amyotrophy (HP:0009129) | 2.48657368 |
| 89 | Biconcave vertebral bodies (HP:0004586) | 2.48581246 |
| 90 | Elbow flexion contracture (HP:0002987) | 2.48256029 |
| 91 | Abnormality of serum amino acid levels (HP:0003112) | 2.48135914 |
| 92 | Joint stiffness (HP:0001387) | 2.46979879 |
| 93 | Menorrhagia (HP:0000132) | 2.46887542 |
| 94 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.46365281 |
| 95 | Mucopolysacchariduria (HP:0008155) | 2.46365281 |
| 96 | Premature rupture of membranes (HP:0001788) | 2.46237743 |
| 97 | Mitral stenosis (HP:0001718) | 2.46201182 |
| 98 | Mitral valve prolapse (HP:0001634) | 2.44160706 |
| 99 | Spastic diplegia (HP:0001264) | 2.41697418 |
| 100 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.37841523 |
| 101 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.37841523 |
| 102 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.37841523 |
| 103 | Disproportionate tall stature (HP:0001519) | 2.37703626 |
| 104 | Hyperextensible skin (HP:0000974) | 2.36396659 |
| 105 | Amyloidosis (HP:0011034) | 2.35060956 |
| 106 | Esophageal varix (HP:0002040) | 2.34960886 |
| 107 | Abnormality of the acetabulum (HP:0003170) | 2.34559086 |
| 108 | Bowel diverticulosis (HP:0005222) | 2.33243397 |
| 109 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.31026577 |
| 110 | Glomerulonephritis (HP:0000099) | 2.30540351 |
| 111 | Hemorrhage of the eye (HP:0011885) | 2.27836082 |
| 112 | Achilles tendon contracture (HP:0001771) | 2.27471158 |
| 113 | Right ventricular cardiomyopathy (HP:0011663) | 2.27290799 |
| 114 | Delayed CNS myelination (HP:0002188) | 2.25031399 |
| 115 | Pancreatitis (HP:0001733) | 2.22794473 |
| 116 | Abnormal gallbladder morphology (HP:0012437) | 2.21418755 |
| 117 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.20499740 |
| 118 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.20499740 |
| 119 | Abnormality of glycolipid metabolism (HP:0010969) | 2.20499740 |
| 120 | Nephritis (HP:0000123) | 2.19336191 |
| 121 | Overgrowth (HP:0001548) | 2.19093289 |
| 122 | Hypoventilation (HP:0002791) | 2.18518652 |
| 123 | Metabolic acidosis (HP:0001942) | 2.18417909 |
| 124 | Cholelithiasis (HP:0001081) | 2.18205064 |
| 125 | Gingival bleeding (HP:0000225) | 2.16448253 |
| 126 | Distal lower limb amyotrophy (HP:0008944) | 2.15973734 |
| 127 | Natal tooth (HP:0000695) | 2.14086359 |
| 128 | Aortic valve stenosis (HP:0001650) | 2.13261916 |
| 129 | Abnormal cartilage morphology (HP:0002763) | 2.10635139 |
| 130 | Generalized amyotrophy (HP:0003700) | 2.10466442 |
| 131 | Opisthotonus (HP:0002179) | 2.10009211 |
| 132 | Thin bony cortex (HP:0002753) | 2.07973811 |
| 133 | Cholecystitis (HP:0001082) | 2.06676079 |
| 134 | Abnormal gallbladder physiology (HP:0012438) | 2.06676079 |
| 135 | Lethargy (HP:0001254) | 2.05831098 |
| 136 | Dicarboxylic aciduria (HP:0003215) | 2.05058063 |
| 137 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.05058063 |
| 138 | Ectopia lentis (HP:0001083) | 2.05040823 |
| 139 | Distal lower limb muscle weakness (HP:0009053) | 2.05013337 |
| 140 | Hypoglycemic seizures (HP:0002173) | 2.03481683 |
| 141 | Ulnar bowing (HP:0003031) | 2.02899093 |
| 142 | Wrist flexion contracture (HP:0001239) | 2.01974992 |
| 143 | Broad face (HP:0000283) | 2.00450993 |
| 144 | Coronal craniosynostosis (HP:0004440) | 2.00371645 |
| 145 | Hypochromic microcytic anemia (HP:0004840) | 2.00006961 |
| 146 | Hyperacusis (HP:0010780) | 1.99360972 |
| 147 | Rectal prolapse (HP:0002035) | 1.99270123 |
| 148 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97691104 |
| 149 | Camptodactyly of toe (HP:0001836) | 1.97587154 |
| 150 | Hydroxyprolinuria (HP:0003080) | 1.97197117 |
| 151 | Abnormality of proline metabolism (HP:0010907) | 1.97197117 |
| 152 | Emphysema (HP:0002097) | 1.96565881 |
| 153 | Acanthocytosis (HP:0001927) | 1.96205559 |
| 154 | Back pain (HP:0003418) | 1.95069891 |
| 155 | Aortic dissection (HP:0002647) | 1.94981902 |
| 156 | Hand muscle atrophy (HP:0009130) | 1.94949954 |
| 157 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94747383 |
| 158 | Ovoid vertebral bodies (HP:0003300) | 1.94368171 |
| 159 | Absent frontal sinuses (HP:0002688) | 1.93874777 |
| 160 | Thrombophlebitis (HP:0004418) | 1.92659751 |
| 161 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.91775950 |
| 162 | Irritability (HP:0000737) | 1.91250178 |
| 163 | Abnormality of iron homeostasis (HP:0011031) | 1.90571059 |
| 164 | Increased mean platelet volume (HP:0011877) | 1.90285498 |
| 165 | Delayed cranial suture closure (HP:0000270) | 1.88441074 |
| 166 | Asymmetric septal hypertrophy (HP:0001670) | 1.88406501 |
| 167 | Rickets (HP:0002748) | 1.88344960 |
| 168 | Abnormality of the Achilles tendon (HP:0005109) | 1.88119926 |
| 169 | Late onset (HP:0003584) | 1.87354042 |
| 170 | Neonatal onset (HP:0003623) | 1.87331135 |
| 171 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.86368667 |
| 172 | Abnormal delivery (HP:0001787) | 1.86247198 |
| 173 | Hypophosphatemic rickets (HP:0004912) | 1.83085699 |
| 174 | Nonimmune hydrops fetalis (HP:0001790) | 1.82773251 |
| 175 | Coxa vara (HP:0002812) | 1.82126610 |
| 176 | Sensorimotor neuropathy (HP:0007141) | 1.81562548 |
| 177 | Protruding ear (HP:0000411) | 1.81224739 |
| 178 | Brushfield spots (HP:0001088) | 1.80628187 |
| 179 | Stroke (HP:0001297) | 1.80566936 |
| 180 | Abnormality of the gallbladder (HP:0005264) | 1.80490684 |
| 181 | Pulmonary artery stenosis (HP:0004415) | 1.79517316 |
| 182 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.79419198 |
| 183 | Inguinal hernia (HP:0000023) | 1.77625405 |
| 184 | Femoral bowing (HP:0002980) | 1.76091630 |
| 185 | Obstructive sleep apnea (HP:0002870) | 1.74494107 |
| 186 | Wide anterior fontanel (HP:0000260) | 1.73486962 |
| 187 | Abnormality of skull ossification (HP:0002703) | 1.72143192 |
| 188 | Nuclear cataract (HP:0100018) | 1.69796220 |
| 189 | Premature skin wrinkling (HP:0100678) | 1.69536416 |
| 190 | Arachnodactyly (HP:0001166) | 1.68205803 |
| 191 | Thoracolumbar scoliosis (HP:0002944) | 1.67162194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.25429822 |
| 2 | ERN1 | 4.68864793 |
| 3 | SIK1 | 4.11044690 |
| 4 | TRIB3 | 3.48048397 |
| 5 | FGFR4 | 3.21778036 |
| 6 | PKN2 | 3.01789211 |
| 7 | LATS1 | 2.86868681 |
| 8 | TAOK3 | 2.54799913 |
| 9 | NTRK1 | 2.12746160 |
| 10 | PTK6 | 2.12185595 |
| 11 | PIK3CG | 2.11345607 |
| 12 | PAK4 | 1.96099530 |
| 13 | EPHA2 | 1.92999769 |
| 14 | ERBB4 | 1.92062646 |
| 15 | INSRR | 1.87208887 |
| 16 | SMG1 | 1.78051346 |
| 17 | FRK | 1.75549703 |
| 18 | MYLK | 1.67015595 |
| 19 | MST1R | 1.66200017 |
| 20 | GRK5 | 1.65680016 |
| 21 | RIPK1 | 1.61956640 |
| 22 | ICK | 1.58622418 |
| 23 | CDC42BPA | 1.58128886 |
| 24 | TTN | 1.51255970 |
| 25 | PRKD2 | 1.51042586 |
| 26 | IRAK3 | 1.50892306 |
| 27 | LIMK1 | 1.49599849 |
| 28 | NEK9 | 1.49328368 |
| 29 | MAP3K3 | 1.46255093 |
| 30 | FLT3 | 1.45569547 |
| 31 | PRPF4B | 1.43811598 |
| 32 | EPHA3 | 1.39557180 |
| 33 | GRK6 | 1.38043755 |
| 34 | GRK7 | 1.33897192 |
| 35 | EPHB1 | 1.30369674 |
| 36 | TGFBR2 | 1.29822199 |
| 37 | TYK2 | 1.29637239 |
| 38 | MAPKAPK3 | 1.28784454 |
| 39 | STK38 | 1.26821984 |
| 40 | FER | 1.25933754 |
| 41 | RPS6KA2 | 1.22180148 |
| 42 | PTK2 | 1.21976997 |
| 43 | PDGFRA | 1.21857615 |
| 44 | PIM2 | 1.18696892 |
| 45 | MAPK11 | 1.18271956 |
| 46 | AKT3 | 1.16068011 |
| 47 | TAOK2 | 1.15741294 |
| 48 | ARAF | 1.12822624 |
| 49 | CAMK1D | 1.12618192 |
| 50 | DDR2 | 1.12416117 |
| 51 | STK38L | 1.11866208 |
| 52 | EEF2K | 1.09034911 |
| 53 | MOS | 1.05084186 |
| 54 | MAP3K6 | 1.04603687 |
| 55 | TBK1 | 1.04425490 |
| 56 | MAP2K3 | 0.99102605 |
| 57 | EPHB2 | 0.97620676 |
| 58 | PAK2 | 0.94674768 |
| 59 | KDR | 0.93522520 |
| 60 | ABL2 | 0.93221877 |
| 61 | MET | 0.92073878 |
| 62 | JAK1 | 0.91949522 |
| 63 | PRKG2 | 0.90716182 |
| 64 | PDK2 | 0.88327519 |
| 65 | PRKAA2 | 0.87615307 |
| 66 | MAP3K13 | 0.86156065 |
| 67 | ADRBK1 | 0.85960947 |
| 68 | KIT | 0.85739007 |
| 69 | JAK2 | 0.84624811 |
| 70 | PIK3CA | 0.84554117 |
| 71 | TIE1 | 0.83069102 |
| 72 | BMX | 0.82209624 |
| 73 | LATS2 | 0.81529798 |
| 74 | DYRK1B | 0.81522730 |
| 75 | GRK1 | 0.81401828 |
| 76 | MAP3K7 | 0.80557937 |
| 77 | LRRK2 | 0.80486901 |
| 78 | TRPM7 | 0.79210659 |
| 79 | ADRBK2 | 0.77187466 |
| 80 | ERBB2 | 0.77090393 |
| 81 | MAP2K2 | 0.74981939 |
| 82 | KSR2 | 0.72729856 |
| 83 | MAP2K4 | 0.72671962 |
| 84 | CDK12 | 0.69770228 |
| 85 | MAPK7 | 0.67583947 |
| 86 | STK3 | 0.67497838 |
| 87 | MAP2K1 | 0.66623154 |
| 88 | RPS6KC1 | 0.66347117 |
| 89 | RPS6KL1 | 0.66347117 |
| 90 | MTOR | 0.65833852 |
| 91 | GSK3A | 0.65537560 |
| 92 | PRKD3 | 0.65443057 |
| 93 | ROCK2 | 0.65161348 |
| 94 | TESK2 | 0.64389831 |
| 95 | CDK6 | 0.62164424 |
| 96 | DAPK2 | 0.61623726 |
| 97 | FGFR2 | 0.60307634 |
| 98 | PAK3 | 0.56125889 |
| 99 | MAP3K2 | 0.56101101 |
| 100 | PDK3 | 0.55953727 |
| 101 | PDK4 | 0.55953727 |
| 102 | CAMK1G | 0.55708889 |
| 103 | CDK8 | 0.55577083 |
| 104 | MAP3K1 | 0.54910055 |
| 105 | ILK | 0.54428940 |
| 106 | NUAK1 | 0.53304089 |
| 107 | RET | 0.52905751 |
| 108 | ROCK1 | 0.52557131 |
| 109 | ZAP70 | 0.51081895 |
| 110 | MAPK4 | 0.50829626 |
| 111 | MELK | 0.50441447 |
| 112 | MAP3K10 | 0.50298811 |
| 113 | MARK2 | 0.50004565 |
| 114 | MAPK12 | 0.49927169 |
| 115 | JAK3 | 0.49886089 |
| 116 | MAP3K8 | 0.49852682 |
| 117 | PDGFRB | 0.49493098 |
| 118 | PTK2B | 0.49184035 |
| 119 | SCYL2 | 0.48472925 |
| 120 | CAMK2G | 0.48188607 |
| 121 | FGFR3 | 0.47707455 |
| 122 | IRAK1 | 0.47584753 |
| 123 | CSK | 0.46791543 |
| 124 | MAP3K14 | 0.44678061 |
| 125 | RPS6KA6 | 0.44624310 |
| 126 | HIPK2 | 0.44281422 |
| 127 | MAP3K11 | 0.44074446 |
| 128 | IGF1R | 0.43996784 |
| 129 | PRKCZ | 0.42294535 |
| 130 | DMPK | 0.42065364 |
| 131 | MAPKAPK2 | 0.41063077 |
| 132 | BRAF | 0.40369530 |
| 133 | MAPK15 | 0.38156982 |
| 134 | CLK1 | 0.38130955 |
| 135 | PRKAA1 | 0.38007063 |
| 136 | PDPK1 | 0.37894700 |
| 137 | FGFR1 | 0.35554925 |
| 138 | WNK1 | 0.35512929 |
| 139 | MAP2K6 | 0.34745801 |
| 140 | EGFR | 0.33758463 |
| 141 | IKBKE | 0.33273678 |
| 142 | PAK1 | 0.32914441 |
| 143 | PRKACG | 0.31464307 |
| 144 | NME2 | 0.29289455 |
| 145 | PRKD1 | 0.29183434 |
| 146 | TESK1 | 0.29165527 |
| 147 | LMTK2 | 0.28963723 |
| 148 | DAPK3 | 0.28342417 |
| 149 | CSF1R | 0.27584515 |
| 150 | RPS6KB2 | 0.27327806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.22228694 |
| 2 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 3.27503214 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.26953382 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.11482670 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.93912594 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.86799814 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.84035635 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.56827777 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56683966 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49359890 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.44471667 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.38510509 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.34771713 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33044554 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11418391 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.06263553 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.01187987 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.99374842 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.98979230 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.96105597 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93666415 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88690490 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87731341 |
| 24 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.83445162 |
| 25 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.82783958 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.76926539 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74235793 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73153972 |
| 29 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.70548831 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66676541 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.66636512 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64069477 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64001552 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.59843578 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.54855176 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54665464 |
| 37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.52864233 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.51832919 |
| 39 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.45540646 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42026483 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.41025997 |
| 42 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.40955818 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40413080 |
| 44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.40280731 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36979229 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36966017 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36788269 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.34883845 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27627522 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.22338486 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.22111732 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21703205 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.20520544 |
| 54 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.18122320 |
| 55 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17851422 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.15670011 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15447014 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 1.14856114 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.13844221 |
| 60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.13123064 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.12871793 |
| 62 | Adherens junction_Homo sapiens_hsa04520 | 1.12794339 |
| 63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12763338 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12591242 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 1.10847260 |
| 66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.09459880 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08765223 |
| 68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08749958 |
| 69 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.06210109 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.05933535 |
| 71 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.05922522 |
| 72 | Melanoma_Homo sapiens_hsa05218 | 1.04346029 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03143919 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03037519 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02264832 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.00847447 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.00318187 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.00250173 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99190201 |
| 80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.98732540 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.97179727 |
| 82 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96468707 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95274510 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.94802693 |
| 85 | Pathways in cancer_Homo sapiens_hsa05200 | 0.94575586 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93927009 |
| 87 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93465593 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92055617 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.88605585 |
| 90 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.87948771 |
| 91 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.87447752 |
| 92 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86924363 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85872377 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.85806051 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.85790643 |
| 96 | Prostate cancer_Homo sapiens_hsa05215 | 0.85682216 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84409065 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83692192 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82480655 |
| 100 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.81951159 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81524369 |
| 102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80414123 |
| 103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.80393357 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.79252014 |
| 105 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75761355 |
| 106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.75376039 |
| 107 | Lysine degradation_Homo sapiens_hsa00310 | 0.74508130 |
| 108 | Apoptosis_Homo sapiens_hsa04210 | 0.74069228 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73446342 |
| 110 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.73233399 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72038420 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71116313 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70728243 |
| 114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70371164 |
| 115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69888474 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.69245253 |
| 117 | Gap junction_Homo sapiens_hsa04540 | 0.67832322 |
| 118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67533695 |
| 119 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67257137 |
| 120 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.66462265 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.63384063 |
| 122 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63219615 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62977342 |
| 124 | Tight junction_Homo sapiens_hsa04530 | 0.60861249 |
| 125 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60824168 |
| 126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60796976 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59683605 |
| 128 | Axon guidance_Homo sapiens_hsa04360 | 0.59543704 |
| 129 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57558277 |
| 130 | Melanogenesis_Homo sapiens_hsa04916 | 0.53654393 |
| 131 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52445614 |
| 132 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52389263 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51258868 |
| 134 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.50360842 |
| 135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50225657 |
| 136 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46224937 |
| 137 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45004962 |
| 138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44879240 |
| 139 | Tuberculosis_Homo sapiens_hsa05152 | 0.43718024 |
| 140 | Mineral absorption_Homo sapiens_hsa04978 | 0.43630163 |
| 141 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42882734 |
| 142 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41837511 |
| 143 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38983290 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.38252484 |
| 145 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37497923 |
| 146 | Prion diseases_Homo sapiens_hsa05020 | 0.33321162 |
| 147 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.32780266 |
| 148 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.29708333 |
| 149 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27096681 |
| 150 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26023884 |
| 151 | Bladder cancer_Homo sapiens_hsa05219 | 0.24979866 |
| 152 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.24440268 |
| 153 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23026855 |
| 154 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.13577040 |
| 155 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13132883 |
| 156 | Amoebiasis_Homo sapiens_hsa05146 | 0.12842900 |
| 157 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11982041 |
| 158 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.09828632 |
| 159 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09808379 |
| 160 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.07283878 |
| 161 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.04376481 |
| 162 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.02998977 |
| 163 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.01798590 |
| 164 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1129244 |
| 165 | Protein export_Homo sapiens_hsa03060 | -0.0906824 |
| 166 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0801385 |
| 167 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0752790 |
| 168 | Malaria_Homo sapiens_hsa05144 | -0.0724594 |
| 169 | Focal adhesion_Homo sapiens_hsa04510 | -0.0488373 |
| 170 | Hepatitis C_Homo sapiens_hsa05160 | -0.0449146 |
| 171 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0311540 |
| 172 | Lysosome_Homo sapiens_hsa04142 | -0.0289854 |
| 173 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0198911 |
| 174 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0079403 |

